publication venue for
- Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor.. 6. 2024
- The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLD.. 5. 2024
- Adaptive conductive electrotherapeutic scaffolds for enhanced peripheral nerve regeneration and stimulation.. 4. 2023
- Forecasting cancer: from precision to predictive medicine.. 2. 2021
- Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.. 2. 2020
- Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection. 2021